Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis ...
TMCnet

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...
Investopedia

Diseconomies of Scale Explained: Causes and Impacts on Efficiency

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Erika Rasure is globally-recognized as a leading consumer economics subject ...
BBC

Direction, scale, distance and height

The four main points of the compass are north, east, south and west. Half way between each of these there are four other points: north-east, south-east, south-west and north-west. This makes an ...
BBC

Module 1 (M1) - Handling data - Surveys and sampling

Random close RandomOccurring without a pattern. Unpredictable. sampling is where each member of a population is equally likely to be selected. Possible methods include using a random number generator ...